Engineered phages in anti-infection and anti-tumor fields: A review
- 21 October 2024
- journal article
- research article
- Published by Elsevier in Microbial Pathogenesis
- Vol. 198, 107052
Abstract
No abstract availableKeywords
Funding Information
- Shandong Province Natural Science Foundation (ZR2020MC184, ZR2020MC074)
This publication has 90 references indexed in Scilit:
- Recombination of T4-like Phages and Its Activity against Pathogenic Escherichia coli in Planktonic and Biofilm FormsVirologica Sinica, 2020
- Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant BacteriaCell Host & Microbe, 2019
- Characterization of Non-Infectious Virus-Like Particle Surrogates for Viral Clearance ApplicationsApplied Biochemistry and Biotechnology, 2017
- Effect of a genetically engineered bacteriophage on Enterococcus faecalis biofilmsArchives of Oral Biology, 2016
- Engineering Modular Viral Scaffolds for Targeted Bacterial Population EditingCell Systems, 2015
- Collagen mimetic peptide engineered M13 bacteriophage for collagen targeting and imaging in cancerBiomaterials, 2014
- Engineered phage-based therapeutic materials inhibit Chlamydia trachomatis intracellular infectionBiomaterials, 2012
- Bacteriophages and cancerArchives of Microbiology, 2010
- Targeted gene delivery to mammalian cells by filamentous bacteriophageJournal of Molecular Biology, 1999
- The nucleotide sequence of bacteriophage φX174Journal of Molecular Biology, 1978